This report aims to provide a comprehensive presentation of the global market for In-vitro Lung Model, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-vitro Lung Model.

The In-vitro Lung Model market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global In-vitro Lung Model market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-vitro Lung Model manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global In-vitro Lung Model market size in 2022 is 321.20 million US dollars, and it is expected to be 952.52 million US dollars by 2029, with a compound annual growth rate of 16.80% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the In-vitro Lung Model market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), and InSphero (Switzerland). The share of the top 3 players in the In-vitro Lung Model market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, in which North America accounted for XX%, Europe accounted for XX% of In-vitro Lung Model market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. 2D Cell Models accounted for XX% of In-vitro Lung Model market in 2022. 3D Cell Models share of XX%.
Drug Screening accounted for XX% of the In-vitro Lung Model market in 2022. Toxicology accounts for XX%.

Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, and application division, and then includes research purposes, report timeline, and economic analysis of global regions.
Chapter 2: Analyzes the main companies in the In-vitro Lung Model industry, including their main businesses, products/services, revenue, gross and gross margin.
Chapters 3-5: Segmented the global In-vitro Lung Model market by type, application and region. Analyze the revenue and sales of market segments from different perspectives.
Chapters 6-11: Provide North America, EMEA, China, Asia-Pacific and Latin America In-vitro Lung Model market type, application, country and player market segmentation revenue data.
Chapter 12: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry, and includes industry mergers & acquisitions and industry new entrants and expansion plans.
Chapter 13: The main points and conclusions of the report.

Highlights-Regions

North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Nordic
Latin America
Brazil
Argentina
Mexico
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Player list
Epithelix (Switzerland)
MatTek Corporation (US)
Lonza (Switzerland)
ATCC (US)
InSphero (Switzerland)
Emulate (US)
AlveoliX (Switzerland)
Oncotheis (Switzerland)
Insphero (Switzerland)
TissUse (Switzerland)
Mimetas (Netherlands)
and CN Bio Innovations (UK).

Types list
2D Cell Models
3D Cell Models

Application list
Drug Screening
Toxicology
Others

Table of Content

1 In-vitro Lung Model Market Introduction and Overview
1.1 In-vitro Lung Model Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
2 Players Profiles
2.1 Epithelix (Switzerland)
2.1.1 Epithelix (Switzerland) Company Profile
2.1.2 In-vitro Lung Model Product Overview
2.1.3 Epithelix (Switzerland) In-vitro Lung Model Market Performance (2018-2023)
2.1.4 Epithelix (Switzerland) Business Overview
2.2 MatTek Corporation (US)
2.2.1 MatTek Corporation (US) Company Profile
2.2.2 In-vitro Lung Model Product Overview
2.2.3 MatTek Corporation (US) In-vitro Lung Model Market Performance (2018-2023)
2.2.4 MatTek Corporation (US) Business Overview
2.3 Lonza (Switzerland)
2.3.1 Lonza (Switzerland) Company Profile
2.3.2 In-vitro Lung Model Product Overview
2.3.3 Lonza (Switzerland) In-vitro Lung Model Market Performance (2018-2023)
2.3.4 Lonza (Switzerland) Business Overview
2.4 ATCC (US)
2.4.1 ATCC (US) Company Profile
2.4.2 In-vitro Lung Model Product Overview
2.4.3 ATCC (US) In-vitro Lung Model Market Performance (2018-2023)
2.4.4 ATCC (US) Business Overview
2.5 InSphero (Switzerland)
2.5.1 InSphero (Switzerland) Company Profile
2.5.2 In-vitro Lung Model Product Overview
2.5.3 InSphero (Switzerland) In-vitro Lung Model Market Performance (2018-2023)
2.5.4 InSphero (Switzerland) Business Overview
2.6 Emulate (US)
2.6.1 Emulate (US) Company Profile
2.6.2 In-vitro Lung Model Product Overview
2.6.3 Emulate (US) In-vitro Lung Model Market Performance (2018-2023)
2.6.4 Emulate (US) Business Overview
2.7 AlveoliX (Switzerland)
2.7.1 AlveoliX (Switzerland) Company Profile
2.7.2 In-vitro Lung Model Product Overview
2.7.3 AlveoliX (Switzerland) In-vitro Lung Model Market Performance (2018-2023)
2.7.4 AlveoliX (Switzerland) Business Overview
2.8 Oncotheis (Switzerland)
2.8.1 Oncotheis (Switzerland) Company Profile
2.8.2 In-vitro Lung Model Product Overview
2.8.3 Oncotheis (Switzerland) In-vitro Lung Model Market Performance (2018-2023)
2.8.4 Oncotheis (Switzerland) Business Overview
2.9 Insphero (Switzerland)
2.9.1 Insphero (Switzerland) Company Profile
2.9.2 In-vitro Lung Model Product Overview
2.9.3 Insphero (Switzerland) In-vitro Lung Model Market Performance (2018-2023)
2.9.4 Insphero (Switzerland) Business Overview
2.10 TissUse (Switzerland)
2.10.1 TissUse (Switzerland) Company Profile
2.10.2 In-vitro Lung Model Product Overview
2.10.3 TissUse (Switzerland) In-vitro Lung Model Market Performance (2018-2023)
2.10.4 TissUse (Switzerland) Business Overview
2.11 Mimetas (Netherlands)
2.11.1 Mimetas (Netherlands) Company Profile
2.11.2 In-vitro Lung Model Product Overview
2.11.3 Mimetas (Netherlands) In-vitro Lung Model Market Performance (2018-2023)
2.11.4 Mimetas (Netherlands) Business Overview
2.12 and CN Bio Innovations (UK).
2.12.1 and CN Bio Innovations (UK). Company Profile
2.12.2 In-vitro Lung Model Product Overview
2.12.3 and CN Bio Innovations (UK). In-vitro Lung Model Market Performance (2018-2023)
2.12.4 and CN Bio Innovations (UK). Business Overview
3 Global In-vitro Lung Model Historical and Forecast Market Analysis by Type
3.1 Global In-vitro Lung Model Revenue and Market Share by Type
3.2 Global In-vitro Lung Model Revenue Market Forecast by Type (2023-2029)
4 Global In-vitro Lung Model Historical and Forecast Market Analysis by Application
4.1 Global In-vitro Lung Model Revenue Market Share by Application (2018-2023)
4.2 In-vitro Lung Model Revenue Market Forecast by Application (2023-2029)
5 Global Market Growth Trends Analysis
5.1 Global In-vitro Lung Model Market Size & Forecast (2018-2029)
5.2 In-vitro Lung Model Growth Trends Analysis by Regions
5.2.1 In-vitro Lung Model Market Size by Regions: 2018 VS 2023 VS 2029
5.2.2 In-vitro Lung Model Historic Market Size by Regions (2018-2023)
5.2.3 In-vitro Lung Model Forecasted Market Size by Regions (2023-2029)
5.2.4 North America In-vitro Lung Model Market Size & Forecast (2018-2029)
5.2.5 Europe In-vitro Lung Model Market Size & Forecast (2018-2029)
5.2.6 China In-vitro Lung Model Market Size & Forecast (2018-2029)
5.2.7 Asia-Pacific (Excluding China) In-vitro Lung Model Market Size & Forecast (2018-2029)
5.2.8 Latin America In-vitro Lung Model Market Size & Forecast (2018-2029)
5.2.9 Middle East & Africa In-vitro Lung Model Market Size & Forecast (2018-2029)
6 North America
6.1 North America In-vitro Lung Model Revenue by Players
6.2 North America In-vitro Lung Model Revenue by Types
6.3 North America In-vitro Lung Model Revenue by Applications
6.4 North America In-vitro Lung Model Market by Countries
6.4.1 North America In-vitro Lung Model Revenue by Countries (2018-2029)
6.5 United States
6.6 Canada
7 China
7.1 China In-vitro Lung Model Revenue by Players
7.2 China In-vitro Lung Model Revenue by Types
7.3 China In-vitro Lung Model Revenue by Applications
7.4 China
8 Asia Pacific (Excluding China)
8.1 Asia Pacific In-vitro Lung Model Revenue by Players
8.2 Asia Pacific In-vitro Lung Model Revenue by Types
8.3 Asia Pacific In-vitro Lung Model Revenue by Applications
8.4 Asia Pacific In-vitro Lung Model Market by Countries
8.4.1 Asia Pacific In-vitro Lung Model Revenue by Countries (2018-2029)
8.5 Japan
8.6 Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Europe
9.1 Europe In-vitro Lung Model Revenue by Players
9.2 Europe In-vitro Lung Model Revenue by Types
9.3 Europe In-vitro Lung Model Revenue by Applications
9.4 Europe In-vitro Lung Model Market by Countries
9.4.1 Europe In-vitro Lung Model Revenue by Countries (2018-2029)
9.5 Germany
9.6 France
9.7 UK
9.8 Italy
9.9 Russia
9.10 Nordic
10 Latin America
10.1 Latin America In-vitro Lung Model Revenue by Players
10.2 Latin America In-vitro Lung Model Revenue by Types
10.3 Latin America In-vitro Lung Model Revenue by Applications
10.4 Latin America In-vitro Lung Model Market by Countries
10.4.1 Latin America In-vitro Lung Model Revenue by Countries (2018-2029)
10.5 Brazil
10.6 Argentina
10.7 Mexico
11 Middle East & Africa
11.1 Middle East & Africa In-vitro Lung Model Revenue by Players
11.2 Middle East & Africa In-vitro Lung Model Revenue by Types
11.3 Middle East & Africa In-vitro Lung Model Revenue by Applications
11.4 Middle East & Africa In-vitro Lung Model Market by Countries
11.4.1 Middle East & Africa In-vitro Lung Model Revenue by Countries (2018-2029)
11.5 Egypt
11.6 South Africa
11.7 Israel
11.8 Turkey
11.9 GCC Countries
12 In-vitro Lung Model Industry Dynamic Analysis
12.1 In-vitro Lung Model Market Trends Analysis
12.2 In-vitro Lung Model Market Drivers Analysis
12.3 In-vitro Lung Model Market Challenges Analysis
12.4 In-vitro Lung Model Market Restraints Analysis
12.5 In-vitro Lung Model Industry Mergers & Acquisitions
12.6 In-vitro Lung Model Industry New Entrants and Expansion Plans
13 Research Findings and Conclusion

List of Tables and Figures

Figure In-vitro Lung Model Picture
Table Product Definition of In-vitro Lung Model
Table Global In-vitro Lung Model Market Size by Type (2023 VS 2029)
Table Global In-vitro Lung Model Market Size by Application (2023 VS 2029)
Table Epithelix (Switzerland) Profile
Table Product Overview
Table Epithelix (Switzerland) In-vitro Lung Model Revenue, Gross and Gross Margin (2018-2023)
Figure Epithelix (Switzerland) Revenue and Growth Rate
Figure Epithelix (Switzerland) Revenue Market Share 2017-2022
Table Business Overview
Table MatTek Corporation (US) Profile
Table Product Overview
Table MatTek Corporation (US) In-vitro Lung Model Revenue, Gross and Gross Margin (2018-2023)
Figure MatTek Corporation (US) Revenue and Growth Rate
Figure MatTek Corporation (US) Revenue Market Share 2017-2022
Table Business Overview
Table Lonza (Switzerland) Profile
Table Product Overview
Table Lonza (Switzerland) In-vitro Lung Model Revenue, Gross and Gross Margin (2018-2023)
Figure Lonza (Switzerland) Revenue and Growth Rate
Figure Lonza (Switzerland) Revenue Market Share 2017-2022
Table Business Overview
Table ATCC (US) Profile
Table Product Overview
Table ATCC (US) In-vitro Lung Model Revenue, Gross and Gross Margin (2018-2023)
Figure ATCC (US) Revenue and Growth Rate
Figure ATCC (US) Revenue Market Share 2017-2022
Table Business Overview
Table InSphero (Switzerland) Profile
Table Product Overview
Table InSphero (Switzerland) In-vitro Lung Model Revenue, Gross and Gross Margin (2018-2023)
Figure InSphero (Switzerland) Revenue and Growth Rate
Figure InSphero (Switzerland) Revenue Market Share 2017-2022
Table Business Overview
Table Emulate (US) Profile
Table Product Overview
Table Emulate (US) In-vitro Lung Model Revenue, Gross and Gross Margin (2018-2023)
Figure Emulate (US) Revenue and Growth Rate
Figure Emulate (US) Revenue Market Share 2017-2022
Table Business Overview
Table AlveoliX (Switzerland) Profile
Table Product Overview
Table AlveoliX (Switzerland) In-vitro Lung Model Revenue, Gross and Gross Margin (2018-2023)
Figure AlveoliX (Switzerland) Revenue and Growth Rate
Figure AlveoliX (Switzerland) Revenue Market Share 2017-2022
Table Business Overview
Table Oncotheis (Switzerland) Profile
Table Product Overview
Table Oncotheis (Switzerland) In-vitro Lung Model Revenue, Gross and Gross Margin (2018-2023)
Figure Oncotheis (Switzerland) Revenue and Growth Rate
Figure Oncotheis (Switzerland) Revenue Market Share 2017-2022
Table Business Overview
Table Insphero (Switzerland) Profile
Table Product Overview
Table Insphero (Switzerland) In-vitro Lung Model Revenue, Gross and Gross Margin (2018-2023)
Figure Insphero (Switzerland) Revenue and Growth Rate
Figure Insphero (Switzerland) Revenue Market Share 2017-2022
Table Business Overview
Table TissUse (Switzerland) Profile
Table Product Overview
Table TissUse (Switzerland) In-vitro Lung Model Revenue, Gross and Gross Margin (2018-2023)
Figure TissUse (Switzerland) Revenue and Growth Rate
Figure TissUse (Switzerland) Revenue Market Share 2017-2022
Table Business Overview
Table Mimetas (Netherlands) Profile
Table Product Overview
Table Mimetas (Netherlands) In-vitro Lung Model Revenue, Gross and Gross Margin (2018-2023)
Figure Mimetas (Netherlands) Revenue and Growth Rate
Figure Mimetas (Netherlands) Revenue Market Share 2017-2022
Table Business Overview
Table and CN Bio Innovations (UK). Profile
Table Product Overview
Table and CN Bio Innovations (UK). In-vitro Lung Model Revenue, Gross and Gross Margin (2018-2023)
Figure and CN Bio Innovations (UK). Revenue and Growth Rate
Figure and CN Bio Innovations (UK). Revenue Market Share 2017-2022
Table Business Overview
Table Global In-vitro Lung Model Revenue and Market Size by Type (2018-2023)
Table Global In-vitro Lung Model Revenue and Market Share by Type (2018-2023)
Table Global In-vitro Lung Model Revenue Market Size Forecast by Type (2023-2029)
Table Global In-vitro Lung Model Revenue Market Share Forecast by Type (2023-2029)
Table Global In-vitro Lung Model Revenue Market Size by Application (2018-2023)
Table Global In-vitro Lung Model Revenue Market Share by Application (2018-2023)
Table Global In-vitro Lung Model Revenue Market Size by Application (2023-2029)
Table Global In-vitro Lung Model Revenue Market Share by Application (2023-2029)
Figure Global In-vitro Lung Model Revenue Market Size & Forecast (2018-2029)
Table In-vitro Lung Model Market Size by Regions: 2018 VS 2023 VS 2029
Table In-vitro Lung Model Historic Revenue Market Size by Regions (2018-2023)
Table In-vitro Lung Model Historic Revenue Market Share by Regions (2018-2023)
Table In-vitro Lung Model Forecasted Revenue Market Size by Regions (2023-2029)
Table In-vitro Lung Model Forecasted Revenue Market Share by Regions (2023-2029)
Figure North America In-vitro Lung Model Market Size & Forecast (2018-2029)
Figure Europe In-vitro Lung Model Market Size & Forecast (2018-2029)
Figure China In-vitro Lung Model Market Size & Forecast (2018-2029)
Figure Asia-Pacific (Excluding China) In-vitro Lung Model Market Size & Forecast (2018-2029)
Figure Latin America In-vitro Lung Model Market Size & Forecast (2018-2029)
Figure Middle East & Africa In-vitro Lung Model Market Size & Forecast (2018-2029)
Table North America In-vitro Lung Model Revenue Share by Players 2022
Table North America In-vitro Lung Model Revenue by Types (2018-2023)
Table North America In-vitro Lung Model Revenue Market Share by Types (2018-2023)
Table North America In-vitro Lung Model Revenue by Applications (2018-2023)
Table North America In-vitro Lung Model Revenue Market Share by Applications (2018-2023)
Table North America In-vitro Lung Model Revenue by Countries (2018-2029)
Table North America In-vitro Lung Model Revenue Market Share by Countries (2018-2029)
Figure United States In-vitro Lung Model Revenue and Growth (2018-2029)
Figure Canada In-vitro Lung Model Revenue and Growth (2018-2029)
Table China In-vitro Lung Model Revenue Share by Players 2022
Table China In-vitro Lung Model Revenue by Types (2018-2023)
Table China In-vitro Lung Model Revenue Market Share by Types (2018-2023)
Table China In-vitro Lung Model Revenue by Applications (2018-2023)
Table China In-vitro Lung Model Revenue Market Share by Applications (2018-2023)
Figure China In-vitro Lung Model Revenue and Growth (2018-2029)
Table Asia Pacific In-vitro Lung Model Revenue Share by Players 2022
Table Asia Pacific In-vitro Lung Model Revenue by Types (2018-2023)
Table Asia Pacific In-vitro Lung Model Revenue Market Share by Types (2018-2023)
Table Asia Pacific In-vitro Lung Model Revenue by Applications (2018-2023)
Table Asia Pacific In-vitro Lung Model Revenue Market Share by Applications (2018-2023)
Table Asia-Pacific In-vitro Lung Model Revenue by Countries (2018-2029)
Table Asia-Pacific In-vitro Lung Model Revenue Market Share by Countries (2018-2029)
Figure Japan In-vitro Lung Model Revenue and Growth (2018-2029)
Figure Korea In-vitro Lung Model Revenue and Growth (2018-2029)
Figure Southeast Asia In-vitro Lung Model Revenue and Growth (2018-2029)
Figure India In-vitro Lung Model Revenue and Growth (2018-2029)
Figure Australia In-vitro Lung Model Revenue and Growth (2018-2029)
Table Europe In-vitro Lung Model Revenue Share by Players 2022
Table Europe In-vitro Lung Model Revenue by Types (2018-2023)
Table Europe In-vitro Lung Model Revenue Market Share by Types (2018-2023)
Table Europe In-vitro Lung Model Revenue by Applications (2018-2023)
Table Europe In-vitro Lung Model Revenue Market Share by Applications (2018-2023)
Table Europe In-vitro Lung Model Revenue by Countries (2018-2029)
Table Europe In-vitro Lung Model Revenue Market Share by Countries (2018-2029)
Figure Germany In-vitro Lung Model Revenue and Growth (2018-2029)
Figure France In-vitro Lung Model Revenue and Growth (2018-2029)
Figure UK In-vitro Lung Model Revenue and Growth (2018-2029)
Figure Italy In-vitro Lung Model Revenue and Growth (2018-2029)
Figure Russia In-vitro Lung Model Revenue and Growth (2018-2029)
Figure Nordic In-vitro Lung Model Revenue and Growth (2018-2029)
Table Latin America In-vitro Lung Model Revenue Share by Players 2022
Table Latin America In-vitro Lung Model Revenue by Types (2018-2023)
Table Latin America In-vitro Lung Model Revenue Market Share by Types (2018-2023)
Table Latin America In-vitro Lung Model Revenue by Applications (2018-2023)
Table Latin America In-vitro Lung Model Revenue Market Share by Applications (2018-2023)
Table Latin America In-vitro Lung Model Revenue by Countries (2018-2029)
Table Latin America In-vitro Lung Model Revenue Market Share by Countries (2018-2029)
Figure Brazil In-vitro Lung Model Revenue and Growth (2018-2029)
Figure Argentina In-vitro Lung Model Revenue and Growth (2018-2029)
Figure Mexico In-vitro Lung Model Revenue and Growth (2018-2029)
Table Latin America In-vitro Lung Model Revenue Share by Players 2022
Table Middle East & Africa In-vitro Lung Model Revenue by Types (2018-2023)
Table Middle East & Africa In-vitro Lung Model Revenue Market Share by Types (2018-2023)
Table Middle East & Africa In-vitro Lung Model Revenue by Applications (2018-2023)
Table Middle East & Africa In-vitro Lung Model Revenue Market Share by Applications (2018-2023)
Table Middle East & Africa In-vitro Lung Model Revenue by Countries (2018-2029)
Table Middle East & Africa In-vitro Lung Model Revenue Market Share by Countries (2018-2029)
Figure Egypt In-vitro Lung Model Revenue and Growth (2018-2029)
Figure South Africa In-vitro Lung Model Revenue and Growth (2018-2029)
Figure Israel In-vitro Lung Model Revenue and Growth (2018-2029)
Figure Turkey In-vitro Lung Model Revenue and Growth (2018-2029)
Figure GCC Countries In-vitro Lung Model Revenue and Growth (2018-2029)
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Market Mergers & Acquisitions
Table Market New Entrants and Expansion Plans